rectal cancer

11 · 20 / page

Ask MedXY AI

Latest news

Tag

AIartificial intelligencerectal cancer

AI Model Shows Moderate Accuracy for Predicting Complete Response After Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

By MedXY|Jun 8, 2026

A fine-tuned ensemble of tabular foundation models moderately predicted pathological complete response after TNT and showed potential to support watch-and-wait selection after recalibration.

Adherence to Surveillance in the Watch and Wait Approach for Rectal Cancer

Gastroenterologycancer surveillanceNonoperative Management

rectal cancer

Latest news

AI Model Shows Moderate Accuracy for Predicting Complete Response After Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Adherence to Surveillance in the Watch and Wait Approach for Rectal Cancer

Rectal Cancer Accreditation Was Linked to Higher Hospital Volume Without More Care Fragmentation

The Bottom-Up Revolution: How New Surgical Techniques are Saving Lives and Lifestyles in Rectal Cancer

Personalizing Neoadjuvant Intensity: 5-Year CinClare Data Validate UGT1A1-Guided Irinotecan for Rectal Cancer

A 30-Day Mortality Risk Score After Proctectomy for Rectal Cancer: What the NCDB Tells Us and How to Use It

Total Neoadjuvant Therapy Enables Organ Preservation Without Compromising Distant Control in pMMR/MSS Stage II–III Rectal Cancer: Insights from the NO-CUT Trial

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Real-World Insights from an International Consortium

Dual Immune Checkpoint Blockade with Neoadjuvant Chemoradiotherapy in Rectal Cancer: Insights from the CHINOREC Trial

Advancing Organ Preservation in Locally Advanced Rectal Cancer: Insights from the CAO/ARO/AIO-16 Phase 2 Trial

Short-Course Radiotherapy Plus Sintilimab and Chemotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Insights from the SPRING-01 Trial